A pulmonary embolism (PE) is a type of venous thromboembolism ... and then travel to your pulmonary arteries. The exact treatment for PE depends on its severity and whether you need critical ...
8don MSN
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
Shatti, head of the Cardiac Catheterization Unit at Al-Dabous Center at Al-Adan Hospital, announced that the hospital has ...
GlobalData on MSN1d
Penumbra reveals positive data for algorithm-assisted thrombectomy techPenumbra has developed a microprocessor with thrombus removal algorithms that, combined with audio-visual feedback, help ...
The FlowTriever system is 510(k)-Cleared by FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium. Inari Medical NewsMORE Related Stocks ...
Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...
(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.
Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) recently awarded a $3.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback